Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
Egrifta (tesamorelin) has been approved for the treatment of HIV-associated lipodystrophy, according to a November 10 announcement from...
HIV-positive people are aging faster than those not infected HIV, possibly due to the body’s hyperactive response to the virus.
Montreal-based Theratechnologies announced yesterday that the U.S. Food and Drug Administration (FDA) will reschedule its meeting with...
If approved, tesamorelin will be sold in the United States by EMD Serono.
A new non-nuke, the apparent cure of an HIV-positive patient receiving a bone marrow transplant and the possibility of earlier...
The company also confirmed a proposed deal with EMD Serono to sell the drug in the United States once it is approved.
Treatment with a tesamorelin resulted in a significant loss of visceral adipose tissue (VAT)—deep belly fat—compared with a placebo
Opportunistic infection management is inching back into the research spotlight with HIV control.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.